Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells

Abstract

Related Adhesion Focal Tyrosine Kinase (RAFTK; also known as Pyk2), is a member of the Focal Adhesion Kinase (FAK) subfamily and is activated by TNFα, UV light and increases in intracellular calcium levels. However, the function of RAFTK remains largely unknown. Our previous studies demonstrated that treatment with dexamethasone (Dex), ionizing radiation (IR), and anti-Fas mAb induces apoptosis in multiple myeloma (MM) cells. In the present study, we examined the potential role of RAFTK during induction of apoptosis in human MM cells triggered by these three stimuli. Dex-induced apoptosis, in contrast to apoptosis triggered by anti-Fas mAb or IR, is associated with activation of RAFTK. Transient overexpression of RAFTK wild type (RAFTK WT) induces apoptosis, whereas transient overexpression of Kinase inactive RAFTK (RAFTK K-M) blocks Dex-induced apoptosis. In contrast, transient overexpression of RAFTK K-M has no effect on apoptosis triggered by IR or Fas. In Dex-resistant cells, Dex does not trigger either RAFTK activation or apoptosis. Finally, interleukin-6 (IL-6), a known survival factor for MM cells, inhibits both activation of RAFTK and apoptosis of MM.1S cells triggered by Dex. Our studies therefore demonstrate Dex-induced RAFTK-dependent, and IR or Fas induced RAFTK-independent apoptotic signaling cascades in MM cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Astier A, Avraham H, Manie SN, Groopman J, Canty T, Avraham S and Freedman AS. . 1997a J. Biol. Chem. 272: 228–232.

  • Asteir A, Manie SN, Avraham H, Hirai H, Law SF, Zhang Y, Golemis EA, Yigong F, Druker BJ, Hagayeghi, Freedman AS and Avraham S. . 1997b J. Biol. Chem. 272: 19719–19724.

  • Avraham E, London R, Fu Y, Ota S, Hiregowdara J, Li S, Jiang S, Pastroz JM, White RA, Groopman JE and Avraham H. . 1995 J. Biol. Chem. 270: 27742–27751.

  • Avraham S and Avraham H. . 1997 Leuk & Lymph. 27: 247–256.

  • Berg NN and Ostergaard HL. . 1997 J. Immunol. 159: 1753–1757.

  • Chauhan D, Kharbanda SM, Ogata A, Urashima M, Teoh G, Robertson M, Kufe DW and Anderson KC. . 1997b Blood 89: 227–234.

  • Chauhan D, Pandey P, Ogata A, Urashima M, Teoh G, Kharbanda SM and Anderson KC. . 1997a Oncogene 15: 837–843.

  • Chauhan D, Pandey P, Ogata A, Teoh G, Krett N, Halgren R, Rosen ST, Kufe DW, Kharbanda SM and Anderson KC. . 1997c J. Biol. Chem. 272: 29995–29997.

  • Chauhan D, Kharbanda S, Urashima M, Malik N, Frank D, Kufe DW and Anderson KC. . 1995 J. Exp. Med. 182: 1801–1806.

  • Derkinderen P, Siciliano J, Toutant M and Girault JA. . 1998 Euro. J. Neuro. 10: 1667–1675.

  • Dikic I, Dikic I and Schlessinger J. . 1998 J. Biol. Chem. 23: 14301–14308.

  • Hamel W, Dazin P and Israel MA. . 1996 Cytometry 25: 173–181.

  • Hardin J, Macleod S, Grigorieva I, Chang R, Barlogie B, Xiao H and Epstein J. . 1994 Blood 84: 3063–3071.

  • Hardin JA, Sherr DH, DeMaria MA and Lopez PA. . 1992 J. Immunol. Methods. 154: 99–107.

  • Hiregowdara D, Avraham H, Fu Y, London R and Avraham S. . 1997 J. Biol. Chem. 272: 10804–10810.

  • Klein B, Zhang XG, Lu ZY and Bataille R. . 1995 Blood 85: 863–872.

  • Lev SH, Moreno R, Martinez P, Canoll E, Peles JM, Musacchio JM, Plowman GO, Rudy B and Schlessinger J. . 1995 Nature 376: 737–745.

  • Li Xiong Dy RC, Cance WG, Graves LM and Earp HS. . 1999 J. Biol. Chem. 274: 8917–8924.

  • Pandey P, Avraham S, Place A, Kumar V, Majumder PK, Cheng K, Nakazawa A, Saxena S and Kharbanda S. . 1999 J. Biol. Chem. 274: 8618–8623.

  • Pandey P, Avraham S, Kumar S, Nakazawa A, Place A, Ghanem L, Rana A, Kumar V, Majumder PK, Avraham H, Davis R and Kharbanda S. . 1999 J. Biol. Chem. 274: 10140–10144.

  • Salgia R, Avraham S, Pisick E, Li J, Raja S, Greenfield E, Sattler M, Avraham H and Griffin JD. . 1996 J. Biol. Chem. 271: 31222–31226.

  • Sasaki H, Nagura K, Ishimo M, Tobioka H, Kotani K and Sasaki T. . 1995 J. Biol. Chem. 270: 21206–21219.

  • Swanson KD, Reigh C and Landreth GE. . 1998 J. Biol. Chem. 273: 19965–19971.

  • Tokiwa G, Dikic I, Lev S and Schlessinger J. . 1996 Science 273: 792–794.

  • Tsuchida M, Knechtle SJ and Hamawy MM. . 1999 J. Biol. Chem. 274: 6735–6740.

  • Thornberry AT, Rosen A and Nicholson DW. . 1997 In: Kaufmann SH (ed). Apoptosis. Academic Press: San Diego, CA p. 155.

    Google Scholar 

  • Verheij M, Bose R, Lin X-H, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z and Kolesnick RN. . 1996 Nature 380: 75–79.

  • Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME. . 1995 Science 270: 1326–1331.

  • Xiong WC and Parsons TJ. . 1997 J. Cell. Biol. 138: 529–539.

  • Xu Fu, Sharma S, Ganer A, Tu Y, Raitano A, Sawyers C and Lichtenstein A. . 1998 Blood 92: 241–251.

  • Yu H, Li X, Marchetto GS, Hunter D, Calvo B, Dawson TL, Wilm M, Anderegg RJ, Graves LM and Earp HS. . 1996 J. Biol. Chem. 271: 29993–29998.

Download references

Acknowledgements

We thank Dr Hawa Avraham for anti-RAFTK Ab; for GFP-RAFTK, RAFTK K457M (K-M), RAFTK Y402F, and RAFTK wild type (WT) constructs; and for critical reading of the manuscript. Drs Erica Golemis and Arnold Freedman kindly provided the GST-HEF constructs. This investigation was supported by PHS grants CA50947 (K Anderson) and CA75216 (S Kharbanda) awarded by the National Cancer Institute, a Kathy Giusti Multiple Myeloma Research Foundation Fellowship (D Chauhan), and DHHS grant HL55445 (S Avraham). Hervé Husson is supported by the Association pour la Recherche sur le Cancer (ARC).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chauhan, D., Hideshima, T., Pandey, P. et al. RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells. Oncogene 18, 6733–6740 (1999). https://doi.org/10.1038/sj.onc.1203082

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203082

Keywords

This article is cited by

Search

Quick links